Company information

Company listing information, company shareholders as well as key dates and contact details.

This share factsheet isn’t an investment recommendation. We don’t offer personal advice so if you’re unsure, please seek independent advice. Remember, the value of investments can fall as well as rise and you may get back less than you invest.

Business summary

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Brands

None

Listing information

  • Share information

  • EPIC: VAL
  • Sector: Pharmaceuticals & Biotechnology
  • ISIN: GB00BLH13C52
  • Market Sector: AIM
  • Market Segment: ASX1
  • Main Indices: FTSE AIM All-Share
  • Country of register: Great Britain
  • Currency: British Pound
  • Market Cap: £2.22m
  • NMS: 10,000
  • Shares in issue: 132.35m
  • Date Listed: 07-01-2002
  • Registrar: n/a
  • Exchange: London stock exchange
  • Additional listings

  • Domestic listings: LSE:AZHA
  • Overseas listings: n/a

Key dates

  • Dividends

  • Ex-div date (interim): n/a
  • Latest Pay Date (interim): n/a
  • View dividends
  • Meetings

  • AGM: 20/06/2024
  • EGM: 13/02/2009

Company shareholders

Last updated 31/12/2023

*Major shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

View company shareholders breakdown

Contact details

Address: Stonebridge House, Chelmsford Road, Hatfield Heath, United Kingdom, CM22 7BD

Website: n/a

Telephone: http://www.valirx.com

Thinking about investing?

In order to invest, you’ll first need to be a Smart Investor customer. Compare our accounts and choose the right one for you.

Compare accounts

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

Copyright © 2024 Refinitiv, an LSEG business. All rights reserved.